Caxton Associates (New York)’s Cardlytics CDLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-8,574	Closed	-$300K	–	456
2020 Q1	$300K	Buy	8,574 +3,159	+58%	+$111K	0.06%	256
2019 Q4	$340K	Buy	+5,415	New	+$340K	0.05%	241